Lectrona logo Boehringer Ingelheim

Funding Opportunities for
External Research Grants

The mission of the External Research Grants Program for Investigators is to support the advancement of scientific knowledge regarding Boehringer lngelheim’s products and therapeutic areas of interest, through support of original research proposals in areas of scientific interest to Boehringer lngelheim.

The External Research Grants Program is offered to all academic and community-based scientists, individually or through consortia. This program allows investigators to submit proposals for consideration where they may independently execute research as Investigator Initiated Studies (IIS) or work collaboratively with Boehringer lngelheim in External Collaborative Research (ECR) to execute their research.

  • Boehringer lngelheim does not assume regulatory responsibility for either type of external research
  • Investigators serve as Sponsor-Investigator for both IIS and ECR studies
  • Scope must be aligned with a predefined disease area of interest
  • May involve financial support and/or provision of BI drugs or compounds
  • Budgets will be subject to fair market value analysis
  • Can include interventional or non-interventional designs

Investigator Initiated Studies (IIS)

  • Grant funding to support novel pre-clinical, clinical, or health outcomes research studies
  • Sponsor-investigators independently propose and conduct the research

External Collaborative Research (ECR)

  • Grant funding to support clinical or health outcomes studies where Boehringer lngelheim may contribute to the study design
  • The Sponsor-Investigator or Boehringer Ingelheim may propose the research, however Boehringer Ingelheim is not the regulatory sponsor
  • Boehringer Ingelheim may contribute to some extent in the creation of the study design, including providing suggestions or feedback on the study design, protocol, execution, analysis and publication of the results
  • ECR is limited to the conduct of clinical research